/>i
On May 5, 2025, a coalition of U.S. biotechnology companies announced the launch of the American Biotech Innovation Alliance (ABIA). ABIA states that it will “focus on a shared objective: to sustain and strengthen America’s leadership in biotech innovation.” ABIA will work to develop a new roadmap to support the biotech ecosystem. According to ABIA, leaders from across the U.S. biotech industry and research sectors will develop a national innovation strategy outlining the policy, investment, and structural priorities that can help the United States “sustain its leadership position on the global stage.” “Vision 2030: A National Innovation Plan for American Biotech” will:
- Establish the unique identity of the biotech industry;
- Strengthen the innovation pipeline as a whole by bolstering early stage research and developing the next generation of talent;
- Advocate for a modern, flexible regulatory environment; and
- Stimulate and support patient-centric scientific innovation and treatment delivery.
